➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Johnson and Johnson
AstraZeneca
Dow
Boehringer Ingelheim

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

Patent: 6,150,514

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,150,514
Title: 14 Kilobase deletion in the promoter region of BRCA1 in a breast cancer family
Abstract:A 14 kb deletion in the promoter region of a BRCA1 gene has been found in a kindred which had earlier been linked to BRCA1. This deletion is apparently the result of unequal crossing over between two Alu repeats, one of which is 5\' upstream of the start of the coding region and the second which is within intron 2. The deletion results in exons 1a, 1b and 2 being deleted from the gene with the result that the gene cannot be transcribed.
Inventor(s): Swensen; Jeff (Salt Lake City, UT)
Assignee: University of Utah Research Foundation (Salt Lake City, UT)
Application Number:09/056,762
Patent Claims:see list of patent claims

Details for Patent 6,150,514

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial University of Utah Research Foundation (Salt Lake City, UT) 2017-04-09 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial University of Utah Research Foundation (Salt Lake City, UT) 2017-04-09 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial University of Utah Research Foundation (Salt Lake City, UT) 2017-04-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Baxter
McKesson
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.